147 related articles for article (PubMed ID: 11126524)
1. Efficacy and tolerability of lercanidipine in monotherapy in elderly patients with isolated systolic hypertension.
Barbagallo M; Barbagallo Sangiorgi G
Aging (Milano); 2000 Oct; 12(5):375-9. PubMed ID: 11126524
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.
Na SH; Lee HY; Hong Baek S; Jeon HK; Kang JH; Kim YN; Park CG; Ryu JK; Rhee MY; Kim MH; Hong TJ; Choi DJ; Cho SW; Cha DH; Jeon ES; Kim JJ; Shin JH; Park SH; Lee SH; John SH; Shin ES; Kim NH; Lee SY; Kwan J; Jeong MH; Kim SW; Jeong JO; Kim DW; Lee NH; Park WJ; Ahn JC; Won KH; Uk Lee S; Cho JH; Kim SK; Ahn T; Hong S; Yoo SY; Kim SY; Kim BS; Juhn JH; Kim SY; Lee YJ; Oh BH
Clin Ther; 2015 Aug; 37(8):1726-39. PubMed ID: 26164786
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
Agrawal R; Marx A; Haller H
J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators.
Omboni S; Zanchetti A
J Hypertens; 1998 Dec; 16(12 Pt 1):1831-8. PubMed ID: 9869018
[TBL] [Abstract][Full Text] [Related]
5. A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension.
James IG; Jones A; Davies P
J Hum Hypertens; 2002 Aug; 16(8):605-10. PubMed ID: 12149668
[TBL] [Abstract][Full Text] [Related]
6. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.
Mancia G; Omboni S; Chazova I; Coca A; Girerd X; Haller H; Parati G; Pauletto P; Pupek-Musialik D; Svyshchenko Y;
J Hypertens; 2016 Jan; 34(1):139-48. PubMed ID: 26630216
[TBL] [Abstract][Full Text] [Related]
7. Lercanidipine vs lacidipine in isolated systolic hypertension.
Millar-Craig M; Shaffu B; Greenough A; Mitchell L; McDonald C
J Hum Hypertens; 2003 Nov; 17(11):799-806. PubMed ID: 14578921
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of lercanidipine in mild to moderate hypertension among Asians of different ethnic groups.
Chia YC; Yeoh ES; Ng CJ; Khoo EM; Chua CT
Singapore Med J; 2009 May; 50(5):500-5. PubMed ID: 19495520
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of lercanidipine, lacidipine, and nifedipine gastrointestinal therapeutic system on blood pressure and heart rate in elderly hypertensive patients: the ELderly and LErcanidipine (ELLE) study.
Cherubini A; Fabris F; Ferrari E; Cucinotta D; Antonelli Incalzi R; Senin U
Arch Gerontol Geriatr; 2003; 37(3):203-12. PubMed ID: 14511846
[TBL] [Abstract][Full Text] [Related]
10. Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine.
Lund-Johansen P; Stranden E; Helberg S; Wessel-Aas T; Risberg K; Rønnevik PK; Istad H; Madsbu S
J Hypertens; 2003 May; 21(5):1003-10. PubMed ID: 12714876
[TBL] [Abstract][Full Text] [Related]
11. Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial.
Borghi C; Prandin MG; Dormi A; Ambrosioni E;
Blood Press Suppl; 2003 May; 1():14-21. PubMed ID: 12800983
[TBL] [Abstract][Full Text] [Related]
12. Lercanidipine in hypertension.
Borghi C
Vasc Health Risk Manag; 2005; 1(3):173-82. PubMed ID: 17319103
[TBL] [Abstract][Full Text] [Related]
13. Effects of lercanidipine versus amlodipine in hypertensive patients with cerebral ischemic stroke.
Cao TS; Huynh VM; Tran VH
Curr Med Res Opin; 2015 Jan; 31(1):163-70. PubMed ID: 25425058
[TBL] [Abstract][Full Text] [Related]
14. Lercanidipine in the treatment of hypertension.
Beckey C; Lundy A; Lutfi N
Ann Pharmacother; 2007 Mar; 41(3):465-73. PubMed ID: 17341540
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and acceptability of lercanidipine are not age dependent in patients with essential hypertension: the AGATE study].
Poncelet P; Ribstein J; Goullard L; Bassous M; Grès CS; Clerson P
Ann Cardiol Angeiol (Paris); 2004 Jun; 53(3):123-30. PubMed ID: 15291167
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE Study. Eficacia de Lercanidipino y su Perfil de Seguridad.
Barrios V; Navarro A; Esteras A; Luque M; Romero J; Tamargo J; Prieto L; Carrasco JL; Herranz I; Navarro-Cid J; Ruilope LM;
Blood Press; 2002; 11(2):95-100. PubMed ID: 12035878
[TBL] [Abstract][Full Text] [Related]
17. Lercanidipine: a review of its use in hypertension.
McClellan KJ; Jarvis B
Drugs; 2000 Nov; 60(5):1123-40. PubMed ID: 11129125
[TBL] [Abstract][Full Text] [Related]
18. Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study.
Barrios V; Escobar C; Navarro A; Barrios L; Navarro-Cid J; Calderón A;
Int J Clin Pract; 2006 Nov; 60(11):1364-70. PubMed ID: 17073834
[TBL] [Abstract][Full Text] [Related]
19. Effects of lercanidipine hydrochloride versus felodipine sustained-release on day-to-day home blood pressure variability.
Xu M; Wu Y; Wang H; Xu X; Zhao S; Zhang M; Jin H; Yan J; Wang B; Gong J; Lu X; Peng J; Dai Q
Curr Med Res Opin; 2016 Oct; 32(sup2):43-52. PubMed ID: 27779454
[TBL] [Abstract][Full Text] [Related]
20. Fixed-dose lercanidipine and enalapril in field practice: a meta-analysis.
Rizzoni D
Curr Med Res Opin; 2016 Oct; 32(sup2):13-15. PubMed ID: 27779457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
